by Jazz | Oct 5, 2023 | Myrovlytis Trust Blog
We are pleased to announce that we have funded the creation and maintenance of the FOSTER consortium website. In the last 30 years there has been little change to osteosarcoma treatment or survival. We now have an opportunity to change this through the FOSTER (Fight...
by Katie Nightingale | Apr 18, 2023 | Myrovlytis Trust Blog
The British Sarcoma Group (BSG) annual conference took place on March 22nd – 23rd 2023 in Newport, Wales. We were delighted to attend as an exhibitor to promote our Osteosarcoma Now Trial Explorer (ONTEX) and our 2023 grant funding round. It was also inspiring to hear...
by Katie Nightingale | Jan 31, 2023 | Myrovlytis Trust Blog
We are delighted to announce the first group of our 2022 grant holders. After re-establishing the Trust’s grant giving activity in 2021, we were keen to build upon that success and expand our research portfolio. In 2022, we focused on 1 year projects and PhD...
by Jazz | Jan 19, 2023 | Myrovlytis Trust Blog
We are delighted to launch our new improved Osteosarcoma Now Trial EXplorer (ONTEX). ONTEX is an international database that aims to make clinical trial information available and accessible to patients and their families. Each osteosarcoma clinical trial has been...
by Jazz | Dec 22, 2022 | Myrovlytis Trust Blog
Our offices will be closed from Friday 23rd December 2022 and will reopen on Tuesday 3rd January 2023. We will respond to any enquiries upon our return. From all of us at the Myrovlytis Trust, we wish you a wonderful holiday season and a happy new year!
by Jazz | Dec 15, 2022 | Myrovlytis Trust Blog
We were delighted to attend the 2022 ESMO Immuno-Oncology Congress. Held over three days, the event welcomed 1700 people both online and in person. We heard the latest research in the immune-oncology field and how it is being applied in clinical practice. In this...
Recent Comments